Baixe o app para aproveitar ainda mais
Prévia do material em texto
J Physiol 593.21 (2015) pp 4765–4780 4765 Th e Jo u rn al o f Ph ys io lo g y 5′-AMP activated protein kinase α2 controls substrate metabolism during post-exercise recovery via regulation of pyruvate dehydrogenase kinase 4 Andreas Mæchel Fritzen1, Anne-Marie Lundsgaard1,4, Jacob Jeppesen1,3, Mette Landau Brabæk Christiansen1, Rasmus Biensø2, Jason R. B. Dyck5, Henriette Pilegaard2 and Bente Kiens1 1Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, the August Krogh Centre, University of Copenhagen, Copenhagen, Denmark 2Centre of Inflammation and Metabolism, the August Krogh Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark 3Type 2 Diabetes and Obesity Pharmacology, Novo Nordisk A/S, Maaloev, Denmark 4Danish Diabetes Academy, Odense University Hospital, Odense, Denmark 5Cardiovascular Research Centre, Alberta Diabetes Institute, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada Key points � There is lower fat oxidation during post-exercise recovery in mice lacking 5′-AMP activated protein kinase α2 (AMPKα2). � AMPKα2 is involved in post-transcriptional and not transcriptional regulation of pyruvate dehydrogenase kinase 4 (PDK4) in muscle. � Exercise-induced AMPKα2 activity increases PDK4 protein content, in turn inhibiting pyruvate dehydrogenase activity and glucose oxidation. � The mechanism for increased post-exercise fat oxidation is by inhibition of carbohydrate oxidation allowing increased fat oxidation rather than by direct stimulation of fat oxidation. Abstract It is well known that exercise has a major impact on substrate metabolism for many hours after exercise. However, the regulatory mechanisms increasing lipid oxidation and facilitating glycogen resynthesis in the post-exercise period are unknown. To address this, sub- strate oxidation was measured after prolonged exercise and during the following 6 h post-exercise in 5´-AMP activated protein kinase (AMPK) α2 and α1 knock-out (KO) and wild-type (WT) mice with free access to food. Substrate oxidation was similar during exercise at the same relative intensity between genotypes. During post-exercise recovery, a lower lipid oxidation (P < 0.05) and higher glucose oxidation were observed in AMPKα2 KO (respiratory exchange ratio (RER) = 0.84 ± 0.02) than in WT and AMPKα1 KO (average RER = 0.80 ± 0.01) without genotype differences in muscle malonyl-CoA or free-carnitine concentrations. A similar increase in muscle pyruvate dehydrogenase kinase 4 (PDK4) mRNA expression in WT and AMPKα2 KO was observed following exercise, which is consistent with AMPKα2 deficiency not affecting the exercise-induced activation of the PDK4 transcriptional regulators HDAC4 and SIRT1. Inter- estingly, PDK4 protein content increased (63%, P < 0.001) in WT but remained unchanged in AMPKα2 KO. In accordance with the lack of increase in PDK4 protein content, lower (P < 0.01) inhibitory pyruvate dehydrogenase (PDH)-E1α Ser293 phosphorylation was observed in AMPKα2 KO muscle compared to WT. These findings indicate that AMPKα2 regulates muscle metabolism post-exercise through inhibition of the PDH complex and hence glucose oxidation, subsequently creating conditions for increased fatty acid oxidation. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society DOI: 10.1113/JP270821 4766 A. M. Fritzen and others J Physiol 593.21 (Resubmitted 15 June 2015; accepted after revision 2 September 2015; first published online 11 September 2015) Corresponding author B. Kiens: Department of Nutrition, Exercise and Sports, the August Krogh Centre, University of Copenhagen, Universitetsparken 13, 2100 Copenhagen Ø, Denmark. Email: bkiens@nexs.ku.dk Abbreviations ACC, acetyl-CoA carboxylase; AICAR, 5-aminoimidazole-4-carboxamide riboside; AMPK, 5′-AMP activated protein kinase; CT, cycle threshold; FA, fatty acid; HDAC4, histone deacetylase 4; KO, knock-out; LPL, lipoprotein lipase; miR, micro ribonucleic acid; PDH, pyruvate dehydrogenase; PDK4, pyruvate dehydrogenase kinase isoenzyme 4; RER, respiratory exchange ratio; SIRT1, silent information regulator T1; ssDNA, single stranded DNA; TG, triacylglycerol; WT, wild-type. Introduction Several human studies have shown a substantial increase in fatty acid (FA) oxidation in the post-exercise period compared to the resting state. Depending on the intensity and duration of exercise, the enhanced FA oxidation will last for several hours or even days after exercise (Krzentowski et al. 1982; Bielinski et al. 1985; Maehlum et al. 1986; Weststrate et al. 1990; Wolfe et al. 1990; Melby et al. 1993; Calles-Escandon et al. 1996; Treuth et al. 1996; Horton et al. 1998; Kiens & Richter, 1998; Kimber et al. 2003). Even with an increased dietary intake of carbohydrates post-exercise, where a high carbohydrate oxidation would be expected, the contribution of FA for oxidation is high (Bielinski et al. 1985; Kiens & Richter, 1998; Kimber et al. 2003). It appears that muscle glycogen resynthesis after exercise has such a high metabolic priority that utilization of lipids is elevated to cover the energy expenditure in muscle cells (Kiens & Richter, 1998; Kimber et al. 2003). However, the mechanisms regulating the selection of energy substrate towards oxidation or storage in muscle during recovery from exercise remain unsolved. The heterotrimeric AMP-activated protein kinase complex (AMPK), consisting of a catalytic α-subunit (α1 or α2) in combination with a regulatory β- (β1 or β2) and γ-subunit (γ1, γ2 or γ3), is activated by increased AMP:ATP and ADP:ATP ratios and stimulates substrate metabolism (Hardie, 2008; Richter & Ruderman, 2009). A role of AMPK in the regulation of FA oxidation during post-exercise recovery has been suggested from studies in rats (Rasmussen et al. 1998). Here it was shown that malonyl coenzyme A (CoA) content and acetyl-CoA carboxylase (ACC) activity remained suppressed, and FA oxidation enhanced, in skeletal muscle for prolonged peri- ods after submaximal exercise, suggesting a mechanism via malonyl-CoA, ACC and carnitine palmitoyltransferase 1 (CPT1) that allows for the enhanced FA oxidation post-exercise (Rasmussen et al. 1998). The ability of cells to switch between glucose and FAs for oxidation can also be determined by the PDH complex. PDH catalyses the irreversible oxidative decarboxylation of pyruvate into acetyl-CoA. Recent findings suggest that AMPK is engaged in the regulation of the PDH complex. Thus, Klein et al. (2007) showed an increased PDH activity in skeletal muscle from AMPKα2 knock-out (KO) mice compared with wild-type (WT) at rest and during exercise (Klein et al. 2007). A key enzyme in controlling the activity of PDH is pyruvate dehydrogenase kinase 4 (PDK4), which acts by inhibition of PDH activity and thereby pre- venting the entry of pyruvate into the Krebs cycle (Sugden et al. 1993). Furthermore, an increased transcription of PDK4 was found in primary cardiomyocytes from rats when stimulated with 5-aminoimidazole-4-carboxamide riboside (AICAR) (Houten et al. 2009) pointing towards an engagement of AMPK in the regulation of PDK4. Proposed stimulators of PDK4 transcription are both silent information regulator T1 (SIRT1) and histone deacetylase 4 (HDAC4). From studies in C2C12 cells (a mouse myoblast cell line) it was suggested that AMPK stimulated SIRT1 activity (Cantó et al. 2009; Cantó & Auwerx, 2011), and studies in human muscle samples suggested an association between AMPK activity and HDAC4 export from the nucleus (McGee et al. 2009). Together these various findings may indicate that AMPK regulates PDH activity via regulation of the upstream PDK4 in skeletal muscle at rest and during exercise. It could be speculated that the ability to switch towards an increased FA oxidation during post-exercise recovery also could be attributable to AMPK. Support for such a notion are the findings of a deactivation of PDH in human skeletal muscle in thehours following prolonged exercise (Kimber et al. 2003). Accordingly, an increased FA oxidation would allow for a greater proportion of the glucose taken up being directed towards the glycogen synthesis pathway. This is in accordance with the findings that the muscle glycogen levels during post-exercise recovery, after 30–90 min of treadmill running or 2 h of swimming, were lower in mice lacking functional AMPK than in WT (Mu et al. 2003; Barnes et al. 2004; Jørgensen et al. 2005). We therefore hypothesized that AMPK orchestrates the switch in fuel selection towards higher FA oxidation post-exercise by increasing PDK4 protein thereby inhibiting PDH activity. Consequently, the glucose taken up will be directed towards glycogen synthesis rather than oxidation. To test the hypothesis, and since both α1 and α2 AMPK-containing complexes are present in skeletal muscle and potentially could regulate fuel selection post-exercise, we investigated both AMPKα1 and AMPKα2 KO mice and their respective WT littermates in metabolic C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4767 chambers during, and in the period after, an acute exercise bout at the same relative intensity. Methods Ethical approval All experiments as well as the breeding protocol were approved by the Danish Animal Experimental Inspec- torate and complied with the European Convention for the Protection of Vertebrate Animals used for Experiments and other Scientific Purposes. Animals To elucidate whether a role of AMPK in substrate selection post-exercise could be allocated to either AMPKα1 or AMPKα2 containing heterotrimers, female AMPKα1 and AMPKα2 whole-body KO and their respective WT littermates were used. Mice were 12–16 weeks during the characterization experiments and 17–21 weeks at their final termination. The mice were generated as pre- viously described (Viollet et al. 2003; Jørgensen et al. 2004). Briefly, AMPKα1 KO mice were generated on 129sv background, and AMPKα2 KO mice were generated on C57Bl/6 background. In both models, homozygote WT and KO littermates were generated by heterozygote inter-cross breeding. AMPKα2 KO mice have a normal lifespan with body weight, body composition and food intake similar to WT (Viollet et al. 2003). Genotyping was performed by PCR analysis as previously described (Jørgensen et al. 2004; Thomson et al. 2007) and was later verified by immunoblotting. Mice were housed in temperature controlled (22 ± 1°C) facilities, maintained on a 12 h:12 h light–dark cycle, and received standard chow (Altromin, cat. no. 1324; Brogaarden, Lynge, Denmark) and water ad libitum. Treadmill running exercise Mice were studied in the post-exercise recovery period after having performed a prolonged treadmill exercise test. Prior to the treadmill exercise test, all mice were acclimatized on a treadmill apparatus (TSE Systems GmbH, Germany). Acclimatization was performed two times a day, separated by 5 h of rest for 3 days. Thereafter, mice rested 2 days prior to the experimental day. At acclimatization mice first rested for 3 min on the treadmill which was followed by running at a 0% incline: Day 1, 5 min at increasing speed from 7 m min−1 and 5 min at 14 m min−1; Day 2, 5 min at 14 m min−1 and 5 min at 17 m min−1; Day 3, 10 min at 17 m min−1. Thereafter all mice performed a maximal running speed test, in which the mice started at 10.8 m min−1 at a 0% incline. Then the speed was increased by 2.4 m min−1 every 2nd minute until the mice were unable to keep up with treadmill speed. Cut-off speed was defined as the maximal running speed. Measurement of oxygen uptake and respiratory exchange ratio Oxygen uptake and CO2 production were measured using a CaloSys apparatus (TSE Systems, Bad Homburg, Germany) at rest (24 h), during the running test and 6 h into post-exercise recovery in eight mice from each group. The respiratory exchange ratio (RER) was calculated as CO2 production/O2 uptake. FAT utilization was calculated as 19 kJ/l O2 ∗ oxygen uptake (l O2/h/kg)·(100% - ((RER-0.7)/0.3)). For recording during rest, mice were acclimatized to individual cages for 24 h prior to the measurement. The mice were allowed access to food and water ad libitum at all times while housed in individual cages. For recording during exercise, AMPKα1 KO and WT littermates as well as AMPKα2 KO and WT littermates underwent 2 h of treadmill exercise at 50% of average maximal running speed per group. AMPKα1 KO and WT mice ran at 16 m min−1, and AMPKα2 KO and WT mice ran at 13 and 18 m min−1, respectively. After exercise the mice were transferred to individual calorimetric cages and allowed access to chow food and water ad libitum, and O2 uptake and CO2 production were measured during the following 6 h post-exercise recovery period. Thereafter, WT and AMPKα2 KO mice were allocated into a basal, resting group (Rest 1: WT, n = 10; KO, n = 10) and an exercise group (WT, n = 10; KO, n = 10). Another group of WT and AMPKα2 KO mice were allocated into a basal, resting group (Rest 2: WT, n = 9; KO, n = 8) and a recovery group (WT, n = 10; KO, n = 7). In some of the biochemical analyses, only 7–8 samples were used due to either a lack of samples or technical issues. The exercise group performed 2 h of treadmill exercise at 50% of individual group maximal running speed between 16.00 and 18.00 h. The recovery group performed initially 2 h of treadmill exercise at 50% of individual group maximal running speed between 10.00 and 12.00 h and were afterwards placed in individual cages and rested for 6 h with food and water ad libitum. The resting groups (Rest 1 and Rest 2) had free access to water and food until termination. All mice were killed by cervical dislocation at 18.00 h, which was the same standardized time of the day for all animals. Gastro- cnemius and quadriceps muscles were quickly removed and immediately frozen in liquid nitrogen and stored at −80°C until being further processed. In addition, a blood sample was collected from the chest cavity after heart puncture and transferred to Eppendorf tubes containing 30 μl of 200 mM EGTA. The blood was centrifuged in a Dich centrifuge at 18,000 g (type 155SLRC-BK; Ole Dich Instrumentmakers, Denmark) for 3 min, after which C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4768 A. M. Fritzen and others J Physiol 593.21 plasma was collected and stored at −20°C for further analyses. In a previous study muscle glycogen was only partially resynthesized 3 h post-exercise in muscles from mice overexpressing a kinase-dead AMPKα2 as well as in WT mice (Mu et al. 2003), which is why we chose to kill the mice 6 h post-exercise. Muscle and blood metabolites All reagents were from Sigma-Aldrich Denmark (Copenhagen, Denmark) unless stated otherwise. The following was measured in the quadriceps muscle: Glycogen concentration was determined on 5 mg (wet weight) pulverized tissue after acidic hydrolysis and measured spectrophotometrically at 340 nm (Hitachi 912 Automatic Analyser; Boehringer, Mannheim, Germany) (Passonneau et al. 1967; Lowry & Passonneau, 1972). Malonyl-CoA, acetyl-CoA, succinyl-CoA and free CoA were assayed on 10–15 mg (wet wt) pulverized muscle tissue by high-pressure liquid chromatography separation followed by ultraviolet detection as previously described (Stanley et al. 1996). Free carnitine content was determined in �1 mg of freeze-dried and dissected muscle tissue by a radioisotopic assay (Cederblad et al. 1990) as described previously (Roepstorff et al. 2005). NAD+ and NADH content were determined on �1 mg of freeze-dried and dissected muscle tissue using a photometrical NAD/NADH quantification kit (Biovision, Mountain View, CA, USA). Plasma glucose (Wako Chemicals BmbH, Neuss, Germany), plasma fatty acids (FAs) (Wako Chemicals) and plasma triacylglycerol (TG) concentrations (triacylglycerol GPO-PAP kit, Roche Diagnostics, Mannheim, Germany)were measured using enzymatic colorimetric methods (Hitachi 912 automatic analyser; Boehringer, Mannheim, Germany). RNA isolation, reverse transcription and real time PCR Total RNA was isolated from �20 mg pulverized wet muscle tissue from the quadriceps muscle by a guanidinium thiocyanate–phenol–chloroform extraction method (Chomczynski & Sacchi, 1987) with modifications (Pilegaard et al. 2000). Superscript II RNase H−-system and oligo(dT) (Invitrogen, Carlsbad, CA, USA) were used to reverse transcribe the mRNA to cDNA as previously described (Pilegaard et al. 2000). The cDNA samples were diluted to a concentration of 60 μl μg−1 mRNA in nuclease-free H2O. The amount of single stranded DNA (ssDNA) was determined in each cDNA sample using OliGreen reagent (Molecular Probes, Leiden, The Netherlands) according to Lundby et al. (2006). Before reverse transcription of microRNA (miR), RNA samples were diluted to 2 ng RNA μl−1. MicroRNAs were then reverse transcribed to cDNA by using TaqMan Micro- RNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) and miR-specific primer (Applied Biosystems). The reaction was run in a thermal cycler (PTC-200; MJ Research, Waltham, MA, USA). Real time PCR was performed with an ABI 7900 sequence-detection system (Applied Biosystems) and has previously been published (Kiilerich et al. 2010). Primers and TaqMan probes for amplifying a PDK4-specific mRNA fragment were designed using the mouse-specific database from Ensembl (http://www.ensembl.org/index. html) and Primer Express (Applied Biosystems). The probe was 5′-6-carboxyfluorescein (FAM) and 3′-6- carboxy-N,N,N′,N′-tetramethylrhodamine (TAMRA) labelled, and primers and probes were obtained from TAG Copenhagen (Copenhagen, Denmark). The obtained cycle threshold (CT) values reflecting the initial content of the transcript in the samples were converted to an arbitrary amount by using standard curves obtained from a serial dilution of a representative pooled sample. For each sample, the amount of a given target cDNA was normalized to the ssDNA content of the RT sample. The content of miR-107, RNU6B, snoRNA135, snoRNA202 and snoRNA234 was determined by real time PCR (as described above) using predeveloped miR assays containing specific primers and TaqMan probes labelled with 5′-6-carboxyfluorescein and minor groove binder quencher (non-fluorescent) (Applied Biosystems). The obtained CT values reflecting the initial content of the measured miRs in the samples were converted to an arbitrary amount by using standard curves obtained from a serial dilution of a pooled sample made from all samples. Lipoprotein lipase activity Activity of lipoprotein lipase (LPL) was determined in vitro as previously described (Lithell & Boberg, 1978; Kiens et al. 1989). In brief, muscle samples from gastrocnemius muscle (50 mg wet wt) were incubated in a [3H]triolein emulsion. During incubation LPL was released from its vascular binding to heparin sulphate proteoglycans by heparin added to the incubation medium. Moreover, human serum was added as an apolipoprotein C-II donor and albumin as an acceptor of liberated fatty acids. The release of [3H]oleic acid during the last 60 min of the 110 min incubation was used as a measure of the activity of LPL. During this time, the rate of fatty acid release was linear. One nanomole of fatty acid released per minute corresponds to 1 mU LPL enzyme activity. Western blotting Total protein content, phosphorylation and acetylation levels of proteins were determined in muscle lysates. Muscle samples from the quadriceps muscle were C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society http://www.ensembl.org/index.html http://www.ensembl.org/index.html J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4769 freeze-dried and dissected free of all visible adipose tissue, connective tissue and blood under a micro- scope, and �5 mg dry wt was homogenized in ice-cold buffer as previously described (Jeppesen et al. 2010) modified with deacetylase inhibition by adding 10 mM nicotinamide and 1 mM sodium butyrate. Total protein concentration of muscle lysates was determined in triplicates using the bicinchoninic acid (BCA) method with a Pierce BCA protein assay (no. 23227; Pierce Biotechnology, Rockford, IL, USA). A maximal coefficient of variance of 5% was accepted between replicates. All samples were heated (96°C in 5 min) in Laemmli buffer before being subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and semi-dry immunoblotting. The following antibodies against proteins were used: anti-acetyl-CoA carboxylase (ACC) (streptavidin–HRP, product no. P0397: Dako, Glostrup, Denmark), anti-AMPKα1 and anti-AMPKα2 (kindly donated by Dr Hardie, Dundee University, UK). The following primary phospho-specific anti- bodies were used: anti-ACC Ser79 phosphorylation (no. 07-303, Upstate Biotechnology Incorporated, Waltham, MA, USA) (the ACC phospho-specific antibody is raised against a peptide corresponding to the sequence in rat ACC1 containing the Ser79 phosphorylation site, but the antibody also recognises the mouse ACC2 when phosphorylated at the corresponding Ser212), and anti-α-AMPK Thr172 phosphorylation (no. 2535, Cell Signaling Technology, Danvers, MA, USA). Furthermore anti-p53 (no. 2524) and anti-acetylated p53 Lys379 (no. 2570) (Cell Signaling Technology) were used. In addition, protein levels of the PDH-E1α sub- unit, PDH-E1α phosphorylation at Ser293 and Ser300 (Pilegaard et al. 2006) and pyruvate dehydrogenase kinase isozyme 4 (PDK4) protein levels (Kiilerich et al. 2010) were determined using antibodies as previously described. Membranes were probed with enhanced chemiluminescence (ECL+; Amersham Biosciences, Piscataway, NJ, USA), and immune complexes were visualized using a BioRad ChemiDoc MP Imaging System (Hercules, CA, USA). Signals were quantified (Image Lab version 4.0, BioRad) and expressed as arbitrary units. Membranes used for detection of phosphorylated ACC and acetylated p53 were stripped with a buffer containing 100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris HCl and reprobed with the corresponding antibody against the corresponding protein. Loading consistency was verified by Coomassie stain. Coomassie stain after development was performed by submersion of PVDF membranes for 10 min in 0.5% Coomassie Blue G-250 in 50% ethanol–10% acetic acid, removal of excess Coomassie stain with distilled water followed by destaining in 50% ethanol–10% acetic acid until bands were clearly visible. Statistics Data are expressed as means ± SEM. All statistical analyses were performed in SigmaPlot 11.0 (Systat Software, San Jose, CA, USA) using a t test for data in Fig. 1A, B, E and F, a two-way ANOVA with repeated measurements for data in Fig. 1C and D, and a two-way ANOVA for the rest of the data. When ANOVAs revealed significant differences, Student–Newman–Keuls post hoc test was used for multiple comparisons. P < 0.05 was considered statistically significant. Results AMPKα2 KO but not AMPKα1 KO mice have reduced exercise capacity To evaluate metabolism in AMPKα2 KO mice and WT littermates as well as in AMPKα1 KO and their corresponding WT littermates during exercise at the same relative intensity, mice were initially subjected to a maximum running capacity test on a treadmill. The maximum running speed, achieved by the AMPKα2 WT mice, was 38.4 ± 1.2 m min−1, whereas the maximum running speed was reduced by 27% (P < 0.001) in the AMPKα2 KO mice (Fig. 1A) as previously published (Jeppesen et al. 2013). In contrast, the maximum running speed, achieved by the AMPKα1 WT mice, was 32.9 ± 0.8 m min−1 and was similar in AMPKα1 KO mice (Fig. 1B). Indirect calorimetry reveals changes in substrate selection in AMPKα2 KO mice during post-exercise recovery, but not during exercise RER was similar in WT and AMPKα2 KO mice and WT and AMPKα1 KO mice at rest under fed conditions. This similarity was alsofound during 2 h of submaximal treadmill exercise at the same relative intensity (Fig. 1C and D, respectively; RER data in the AMPKα2 KO and WT mice during running from 18 to 36 min have been published elsewhere (Jeppesen et al. 2013)). However, during the first 6 h of the post-exercise recovery period, RER was higher in AMPKα2 KO mice compared to WT (P < 0.05), indicating a lower FA oxidation and a higher glucose oxidation in AMPKα2 KO mice than in WT (Fig. 1C and E). Consistently, calculated fatty acid oxidation was lower in AMPKα2 KO mice than in WT during the 6 h post-exercise recovery period (Fig. 1G). During the post-exercise recovery period, RER in WT mice was lower (P < 0.05) than RER in the resting, non-exercised mice measured at the same circadian hours of the day (from 12.00 to 18.00 h), while this was not the case for the AMPKα2 KO mice. This phenotype was not observed in AMPKα1 KO mice C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4770 A. M. Fritzen and others J Physiol 593.21 (Fig. 1D and F) suggesting that AMPK heterotrimeric complexes containing AMPKα2 rather than AMPKα1 play a role in the metabolic regulation observed post-exercise. Because a difference in RER during post-exercise recovery was observed only in AMPKα2 KO mice, the next experiments focused on investigating the mechanisms by which AMPKα2 regulates substrate selection during post-exercise recovery. AMPKα2 deficient mice have abolished AMPK signalling AMPKα2 protein expression was ablated in quadriceps muscle of AMPKα2 KO mice (Fig. 2A), whereas the AMPKα1 protein expression was higher (P < 0.001) in the AMPKα2 KO muscle compared to WT (Fig. 2B) as previously described (Viollet et al. 2003; Jørgensen et al. 2004). AMPK Thr172 (Fig. 2C) and ACC Ser212 phosphorylation (Fig. 2D) in quadriceps muscle increased (P < 0.001) 4.2- and 2.9-fold, respectively, in WT muscle after exercise. This was completely abolished in AMPKα2 KO muscle. AMPK Thr172 (Fig. 2C) and ACC Ser212 phosphorylation (Fig. 2D) 6 h post-exercise were at Rest 2 levels in both genotypes. Substrate availability during exercise and post-exercise recovery Plasma FA concentration at rest was similar between WT and AMPKα2 KO mice, increased (P < 0.001) with exercise independently of genotype (Table 1) and was similar to Rest 2 levels 6 h post-exercise in both genotypes 50 A C E FD G B 40 30 20 10 0 WT 1.00 0.95 0.90 0.85 0.80 0.75 0.70 0.00 1.00 0.95 0.90 0.85 0.80 0.75 0.70 0.00 0.0 0.5 1.0 1.5 2.0 3 4 5 6 7 8 Time (hours) Time (hours) RecoveryExercise 0.0 0.5 1.0 1.5 2.0 3 4 5 6 7 8 Time (hours) RecoveryExercise WT Exercise test Exercise test RER during exercise and recovery R e s p ir a to ry e xc h a n g e r a ti o R e s p ir a to ry e xc h a n g e r a ti o 1.00 0.95 0.90 0.85 0.80 0.75 0.70 0.00 1.00 0.95 0.90 0.85 0.80 0.75 0.70 0.00 R e s p ir a to ry e xc h a n g e r a ti o R e s p ir a to ry e xc h a n g e r a ti o RER during exercise and recovery Fatty acid oxidation during recovery F A T u ti liz a ti o n ( k J /h r/ k g ) Average RER during recovery Average RER during recovery AMPKα2KO WT AMPKα1KO WT AMPKα2KO AMPKα KO AMPKα KO WT AMPKα KO WT WT AMPKα1KO M a x im u m s p e e d ( m /m in ) M a x im u m s p e e d ( m /m in ) 50 80 70 60 50 40 30 20 10 2 3 4 5 6 7 8 9 40 30 20 10 0 Figure 1. AMPKα2 KO mice are exercise intolerant and display reduced FA oxidation during post-exercise recovery Maximal running speed test in AMPKα2 KO and WT (A) and AMPKα1 KO and WT mice (B). Respiratory exchange ratio (RER) during treadmill running at 50% of maximal running speed and in the following 6 h post-exercise recovery period (C and D) and the average RER during 6 h of post-exercise recovery (E and F) in AMPKα2 KO and WT (C and E) and AMPKα1 KO and WT (D and F). G, fatty acid oxidation calculated as described in Methods in AMPKα2 KO and WT during 6 h of post-exercise recovery. Data are presented as means ± SEM. n = 8. ∗P < 0.05, ∗∗∗P < 0.001 significantly different from WT (main effect of genotype during recovery in C). WT, wild-type; KO, knock-out. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4771 (Table 1). Plasma TG concentration at rest was similar in the two genotypes and remained unchanged after exercise in WT, but decreased (P < 0.05) with exercise in AMPKα2 KO (Table 1). The plasma TG concentration 6 h post-exercise was at Rest 2 levels in both genotypes (Table 1). Since plasma TG concentration decreased with exercise in AMPKα2 KO mice, the activity of LPL, which is the rate-limiting enzyme for hydrolysis of plasma lipoprotein-rich TG, was determined in skeletal muscle. LPL activity in gastrocnemius muscle was similar between WT and AMPKα2 KO at rest and was unaltered after exercise and 6 h post-exercise in both genotypes (Table 1). This could indicate that the decrease in plasma TG during exercise was probably due to a lower secretion of very low density lipoprotein (VLDL) TG from the liver in AMPKα2 KO mice rather than altered plasma TG hydrolysis in skeletal muscle. However, since only maximal LPL activity was measured, it cannot be excluded that acute changes in LPL activity such as allosteric or covalent regulation in the capillary bed were responsible for the observed decrease in plasma TG in AMPKα2 KO mice. Plasma glucose concentration was similar in WT and AMPKα2 KO at rest, and decreased during exercise both in WT and AMPKα2 KO (P < 0.01), but to a greater extent (P < 0.01) in WT compared to AMPKα2 KO (Table 1). Six hours post-exercise plasma glucose concentration was similar to Rest 2 in both genotypes (Table 1). 2.5 R1 A C D E B WTAMPKα2KO AMPKα1 protein AMPKα2 AMPKα1 AMPKα2KO AMPKα2KO pAMPK pACC ACC Coomassie WT WT WTAMPKα2KO WT AMPKα KO WT AMPKα KO WT AMPKα KO R1 R2 R2Rec Rec 50 kDa 50 kDa 50 kDa 250 kDa 250 kDa RecoveryRest 2Rest 1 5 4 3 2 1 0 4 3 2 1 0 Exercise AMPK phosphorylation ACC phosphorylation RecoveryRest 2Rest 1 Exercise Ex Ex R1 R1 R2 R2Rec RecEx Ex 2.0 A M P K α 1 p ro te in ( A U ) p A M P K T h r1 7 2 ( A U ) p A C C S e r2 1 2 /A C C p ro te in ( A U ) 1.5 1.0 0.5 0.0 Rest 1 Rest 2Exercise Recovery Figure 2. Signalling in AMPKα2 KO and WT skeletal muscle A, AMPKα2 protein was absent in AMPKα2 KO muscle. AMPKα1 protein content (B), AMPK Thr172 phosphorylation (C) and ACC Ser212 phosphorylation/ACC protein (D) in quadriceps muscle at rest, immediately after exercise, and 6 h post-exercise recovery. E, representative immunoblots. Data are presented as means ± SEM. n = 7–10. ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from WT or main effect of genotype. #P < 0.05 main effect of exercise, ###P < 0.001 significantly different from rest within WT. AU, arbitrary units; WT, wild-type; KO, knock-out. From one litter, WT and AMPKα2 KO mice were allocated into a basal, resting group (Rest 1/R1) and an exercise group (Ex). From another litter, WT and AMPKα2 KO were allocated into a basal, resting group (Rest 2/R2) and a recovery group (Rec). C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4772 A. M. Fritzen and others J Physiol 593.21 Ta b le 1. Pl as m a su b st ra te s an d lip o p ro te in lip as e ac ti vi ty in g as tr o cn em iu s m u sc le at re st ,a ft er ex er ci se an d af te r 6 h re co ve ry W T A M PK α 2 K O W T A M PK α 2 K O R es t 1 Ex er ci se R es t 1 Ex er ci se R es t 2 R ec o ve ry R es t 2 R ec o ve ry Pl as m a g lu co se (m m o ll −1 ) 9. 61 ± 0. 45 3. 13 ± 0. 35 ## 9. 55 ± 0. 42 6. 30 ± 1. 27 ## ,∗ ∗ 8. 41 ± 0. 37 8. 15 ± 0. 28 8. 93 ± 0. 71 ∗ 9. 88 ± 0. 53 ∗ Pl as m a fa tt y ac id s (μ m o ll −1 ) 93 2 ±24 8 16 02 ± 18 8# ## 66 0 ± 93 14 21 ± 18 3# ## 74 5 ± 90 83 2 ± 71 83 6 ± 92 82 0 ± 11 0 Pl as m a tr ia cy l- g ly ce ro l( m m o ll −1 ) 1. 51 ± 0. 10 1. 60 ± 0. 12 1. 74 ± 0. 03 1. 40 ± 0. 14 # 1. 14 ± 0. 08 1. 28 ± 0. 13 1. 26 ± 0. 17 1. 37 ± 0. 13 LP L ac ti vi ty (m U (g w et w t) −1 ) 81 .0 ± 3. 4 84 .8 ± 2. 9 79 .8 ± 3. 9 79 .6 ± 4. 3 13 0 ± 13 14 1 ± 4. 6 14 6 ± 6. 3 15 4 ± 5. 3 D at a ar e p re se n te d as m ea n s ± SE M .n = 7– 10 .# ## P < 0. 00 1 m ai n ef fe ct o f ex er ci se ;# P < 0. 05 ,# # P < 0. 01 si g n ifi ca n tl y d if fe re n t fr o m re st w it h in g en o ty p e; ∗ P < 0. 05 m ai n ef fe ct o f g en o ty p e; ∗∗ P < 0. 01 si g n ifi ca n tl y d if fe re n t fr o m W T w it h in ex er ci se . O n e m ill iu n it (m U ) o f LP L ac ti vi ty co rr es p o n d s to 1 n m o l o f fa tt y ac id re le as ed p er m in u te . Fr o m o n e lit te r, W T an d A M PK α 2 K O m ic e w er e al lo ca te d in to a b as al ,r es ti n g g ro u p (R es t 1) an d an ex er ci se g ro u p .F ro m an o th er lit te r, W T an d A M PK α 2 K O w er e al lo ca te d in to a b as al , re st in g g ro u p (R es t 2) an d a re co ve ry g ro u p . Skeletal muscle metabolites during exercise and recovery Glycogen content in the quadriceps muscle was generally higher (P < 0.001) in WT compared to AMPKα2 KO muscle, and was decreased (P < 0.001) to a similar level in both genotypes with exercise (Fig. 3A). Thus, the relative decrease for the AMPKα2 KO was less than that for WT. Six hours post-exercise, muscle glycogen content was restored to a higher (P < 0.001) level compared to Rest 2 independent of genotype (Fig. 3A). When calculating the difference between the muscle glycogen level after exercise with muscle glycogen level 6 h post-exercise, a lower absolute average muscle glycogen resynthesis rate during the 6 h post-exercise recovery was observed in AMPKα2 KO muscle (average rate 2.57 mmol (kg wet wt)−1 h−1) compared to WT (average rate 3.36 mmol (kg wet wt)−1 h−1). Malonyl-CoA content in the quadriceps muscle was similar in the two genotypes at rest, decreased (P < 0.01) with exercise independently of genotype and was at Rest 2 levels 6 h post-exercise in both genotypes (Fig. 3B). Free carnitine (Fig. 3C) and cellular free CoA (Fig. 3D) content in quadriceps muscle were similar in WT and AMPKα2 KO muscle at rest and decreased (P < 0.05) after exercise independently of genotype. Six hours post-exercise free carnitine content was at Rest 2 levels in both WT and AMPKα2 KO muscle. AMPKα2 KO mice have blunted exercise-induced PDK4 protein expression and lower NADH content The lower FA oxidation in AMPKα2 KO compared to WT mice during post-exercise recovery could not be explained by altered substrate availability. Furthermore, the switch towards an increased carbohydrate oxidation in AMPKα2 KO rather than FA oxidation as in WT suggests that the AMPKα2 KO mice have impaired mitochondrial substrate regulation during post-exercise recovery. Thus, we hypothesized that AMPKα2 KO muscle displays impaired regulation of the PDH complex. PDK4 protein expression in quadriceps muscle was similar between WT and AMPKα2 KO muscle at rest. Inter- estingly, PDK4 protein expression was increased by 63% with exercise in WT muscle only (Fig. 4A, P < 0.001) compared to Rest 1. Six hours post-exercise, PDK4 protein expression was not statistically different from Rest 2 in both genotypes, but tended (P = 0.06) towards significance in WT. PDK4 protein was unaltered with exercise and in recovery in AMPKα2 KO mice (Fig. 4A). PDH-E1α Ser293 (Fig. 4B) and Ser300 phosphorylation (Fig. 4C) in muscle increased (P < 0.05; P < 0.01, respectively) with exercise independently of genotype with a trend (P = 0.09) towards a larger increase in PDH-E1α Ser293 phosphorylation in WT mice than in AMPKα2 KO C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4773 mice (Fig. 4B). Six hours post-exercise PDH-E1α Ser293 and Ser300 phosphorylation was at Rest 2 levels. The PDH complex is also inhibited by the products NADH and acetyl-CoA, both allosterically and by activation of PDK, respectively. Interestingly, NADH content in quadriceps muscle was higher (P < 0.05) in WT compared to AMPKα2 KO at all time points (Fig. 4D) and decreased (P < 0.001) with exercise, independently of genotype (Fig. 4D). Therefore, AMPKα2 may influence PDH-E1α by dual mechanisms via up-regulation of PDK4 protein and via inhibition through NADH. Six hours post-exercise the NADH content was similar to Rest 2 levels in both WT and AMPKα2 KO (Fig. 4D). Muscle acetyl-CoA content (Fig. 4E) and the acetyl-CoA/free CoA ratio in muscle (Table 2) were similar in WT and AMPKα2 KO at rest and were unaltered immediately after exercise and 6 h post-exercise in both genotypes. Succinyl-CoA content and the NADH/NAD+ ratio in the quadriceps muscle were similar in the two genotypes at rest, decreased (P < 0.01 and P < 0.001, respectively) with exercise independently of genotype and were similar to Rest 2 levels 6 h post-exercise in both genotypes (Table 2). Similar exercise-induced increase in PDK4 mRNA levels, SIRT1 activation and HDAC4 phosphorylation To investigate whether the difference in exercise-induced PDK4 protein expression between genotypes could be related to a transcriptional mechanism, PDK4 gene expression and proposed regulators were assessed. PDK4 mRNA level in the quadriceps muscle was similar in WT and AMPKα2 KO at rest and increased (P = 0.05) with exercise independently of genotype (Fig. 5A). Muscle NAD+ content was similar in the two genotypes at rest and increased (P < 0.001) with exercise independently of genotype (Fig. 5B). The similar increase in NAD+ content with exercise in the two genotypes was accompanied by a similar decrease (P < 0.05) in p53 Lys379 acetylation in quadriceps muscle (Fig. 5C) implying similar SIRT1 activation with exercise in WT and AMPKα2 KO muscle. HDAC4 Ser632 phosphorylation in quadriceps was similar in the two genotypes at rest and decreased (P < 0.05) with exercise independently of genotype (Fig. 5D). To examine whether the difference in exercise-induced PDK4 protein expression between genotypes could be related to a difference in translational regulation, the content of miR-107, a proposed regulator of PDK4 trans- lation, was measured. However, miR-107 level did not change with exercise and was not different between genotypes (Fig. 5E). RNU6B, snoRNA135, snoRNA202 and snoRNA234 mRNA levels were determined as potential endogenous controls, but they all changed with either exercise or genotype. Thus, miR-107 is not shown as normalized to any endogenous control. Even so, when miR-107 level was related to each of the investigated controls, miR-107 still did not change with exercise and was not different between genotypes, thus 25 Muscle glycogen Free carnitine M u s c le g ly c o g e n c o n te n t (m m o l/ k g w .w .) F re e c a rn it in e ( m m o l/ k g . d .w .) F re e C o A ( n m o l/ m g w .w .) M a lo n y l- C o A ( n m o l/ m g w .w .) 20 15 10 5 0 20 Free CoA Malonyl-CoA 15 10 5 0 1.0 0.8 0.6 0.4 0.2 0.0 3.0 2.5 2.0 1.5 1.0 0.5 0.0 WT A B C D AMPKα KO WT AMPKα KO WT AMPKα KO WT AMPKα KO RecoveryRest 2Rest 1 Exercise RecoveryRest 2Rest 1 Exercise RecoveryRest 2Rest 1 Exercise RecoveryRest 2Rest 1 Exercise Figure 3. Content of glycogen (A), malonyl-CoA (B), free carnitine (C) and free CoA (D) in quadriceps muscle at rest, immediately after exercise, and 6 h post-exercise recovery Data are presented as means ± SEM. n = 7–10. #P < 0.05, ###P < 0.001 main effect of exercise. ∗∗∗P < 0.001 main effect of genotype.w.w., wet weight; d.w., dry weight. From one litter, WT and AMPKα2 KO mice were allocated into a basal, resting group (Rest 1) and an exercise group. From another litter, WT and AMPKα2 KO were allocated into a basal, resting group (Rest 2) and a recovery group. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4774 A. M. Fritzen and others J Physiol 593.21 underlining no changes in miR-107 with exercise in either genotype. Discussion Previous studies have shown that FA oxidation is elevated several hours post-exercise in humans, occurring concomitantly with a restoration of muscle glycogen stores (Wolfe et al. 1990; Melby et al. 1993; Kiens & Richter, 1998), even when a carbohydrate-rich diet is consumed (Kiens & Richter, 1998). The mechanisms regulating this selection of energy substrate towards oxidation/resynthesis in skeletal muscle during the recovery from exercise have remained unsolved. It is well known that AMPK deficiency decreases exercise tolerance in mice (Maarbjerg et al. 2009; O’Neill et al. 2011; Jeppesen et al. 2013; Fentz et al. 2015). Therefore, we chose to let mice lacking AMPKα2 and WT littermates exercise at the same relative intensity thereby probably stressing the muscle equally between genotypes during exercise. Accordingly, a greater total amount of exercise at a higher absolute rate of O2 consumption (V̇O2 ) was performed by WT resulting in a greater use of muscle glycogen and plasma glucose during the exercise bout. Despite this, we here demonstrate an equal high relative reliance in both genotypes on FA oxidation for energy production (covering about 80% of energy production) during prolonged and glycogen-depleting exercise. However, immediately post-exercise AMPKα2 KO mice displayed a markedly suppressed FA utilization compared to WT. This phenotype in substrate selection continued for several hours during recovery from exercise and suggests a role for AMPK in regulation of substrate utilization during recovery. We propose that R1 R1 R2 R2Rec RecEx Ex 37 kDa 37 kDa 37 kDa 37 kDa AMPKα2KO AMPKα2KOWT WT pPDH Ser293 PDK4 pPDH Ser300 PDH-E1α Coomassie Rest 1 Rest 2Exercise Recovery Rest 1 Rest 2Exercise Recovery Rest 1 Rest 2Exercise Recovery Rest 1 Rest 2Exercise Recovery Rest 1 Rest 2Exercise Recovery 8 6 4 2 0 100 80 60 40 20 0 2.0 A B C D E F 1.5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 1.0 0.8 0.6 0.4 0.2 0.0 N A D H ( n m o l/ m g d .w .) A c e ty l- C o A ( n m o l/ m g w .w .) WT AMPKα KO WT AMPKα KO WT AMPKα KO WT AMPKα KO WT AMPKα KO P D K 4 p ro te in ( A U ) p P D H S e r /P D H -E 1 α (A U ) p P D H S e r /P D H -E 1 α (A U ) PDH phosphorylation PDH phosphorylation PDK4 protein NADH Acetyl-CoA Figure 4. AMPKα2 KO mice have blunted exercise-induced PDK4 protein expression and lower NADH content in muscle PDK4 protein expression (A), PDH-E1α Ser293 phosphorylation/PDH-E1α protein (B), PDH-E1α Ser300 phosphorylation/PDH-E1α protein (C), NADH content (D) and acetyl-CoA content (E) in quadriceps muscle at rest, immediately after exercise, and 6 h post-exercise recovery. F, representative immunoblots. Data are presented as means ± SEM. n = 7–10. ##P < 0.01, ###P < 0.001 main effect of exercise (D) and significantly different from rest within WT (A); ∗P < 0.05, ∗∗P < 0.01 main effect of genotype; ∗∗∗P < 0.001 significantly different from WT within exercise. AU, arbitrary units. From one litter, WT and AMPKα2 KO mice were allocated into a basal, resting group (Rest 1/R1) and an exercise group (Ex). From another litter, WT and AMPKα2 KO were allocated into a basal, resting group (Rest 2/R2) and a recovery group (Rec). C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4775 Ta b le 2. M et ab o lit es in th e q u ad ri ce p s m u sc le at re st ,a ft er ex er ci se an d af te r 6 h re co ve ry W T A M PK α 2 K O W T A M PK α 2 K O R es t 1 Ex er ci se R es t 1 Ex er ci se R es t 2 R ec o ve ry R es t 2 R ec o ve ry Su cc in yl -C o A (m m o l( m g w et w t) −1 ) 8. 07 ± 0. 56 6. 56 ± 0. 66 ## 7. 54 ± 0. 97 4. 89 ± 0. 20 ## 7. 24 ± 0. 57 7. 05 ± 0. 69 7. 64 ± 0. 75 6. 03 ± 0. 31 A ce ty lC o A /f re e C o A 0. 28 ± 0. 01 0. 29 ± 0. 03 0. 31 ± 0. 02 0. 28 ± 0. 02 0. 33 ± 0. 02 0. 32 ± 0. 01 0. 30 ± 0. 01 0. 33 ± 0. 04 N A D H /N A D + 2. 35 ± 0. 23 0. 85 ± 0. 14 ## # 1. 68 ± 0. 23 0. 75 ± 0. 14 ## # 2. 62 ± 0. 31 2. 76 ± 0. 40 3. 69 ± 0. 73 3. 51 ± 0. 34 D at a ar e p re se n te d as m ea n s ± SE M .n = 7– 10 .# # P < 0. 01 ,# ## P < 0. 00 1 m ai n ef fe ct o f ex er ci se .F ro m o n e lit te r, W T an d A M PK α 2 K O m ic e w er e al lo ca te d in to a b as al ,r es ti n g g ro u p (R es t 1) an d an ex er ci se g ro u p .F ro m an o th er lit te r, W T an d A M PK α 2 K O w er e al lo ca te d in to a b as al ,r es ti n g g ro u p (R es t 2) an d a re co ve ry g ro u p . AMPK promotes lipid oxidation in the recovery period by up-regulation of PDK4 expression, stimulated by prior exercise (during exercise) in turn phosphorylating and inhibiting PDH activity in muscle post-exercise. This would lead to a lower glucose oxidation, which would indirectly drive a demand for an increased FA oxidation. In addition, AMPK deficiency led to lower muscle concentrations of NADH, which is a known activator of PDK4. PDK4 is an important enzyme in the regulation of glucose consumption in skeletal muscle (Rowles et al. 1996; Bowker-Kinley et al. 1998). PDK4 inhibits PDH activity by phosphorylation (Linn et al. 1969), thereby inhibiting the rate-limiting multi-enzyme complex responsible for the irreversible decarboxylation of pyruvate to acetyl-CoA. Recently, an impaired PDH regulation was observed in PDK4 whole-body KO mice during acute muscle contractions ex vivo (Herbst et al. 2012) indicating an important role of PDK4 in metabolic regulation during exercise. In the same mice, a 50% decreased liver but not muscle glycogen synthesis rate was observed in the hours after exercise when pair-fed (Herbst et al. 2014) suggesting that PDK4 may not be involved in the regulation of muscle glycogen repletion post-exercise. However, when not pair-fed, caloric consumption was doubled by PDK4 KO mice compared to WT during post-exercise recovery (Herbst et al. 2014), which in itself indicates an importance of PDK4 during post-exercise recovery. Moreover, the WT and PDK4 KO mice in that study were not littermates and were bred in different facilities making a clear interpretation of these findings difficult. In the present study, exercise increased the PDK4 protein content in muscle from WT mice, but inter- estingly not in AMPKα2 deficient mice. This finding was further supported by the observation of an increased phosphorylation of PDH-E1α at Ser293 during exercise in WT mice, but not AMPKα2 KO muscle. Previously it was shown in pig heart that PDK4 was activated by NADH, in turn inactivating PDH (Garland, 1964; Linn et al. 1969; Cooper et al. 1975; Ravindran et al. 1996). Here, we show that AMPKα2 deficient muscles generally have reduced NADH content strengthening the point that AMPKα2 KO mice have impaired suppression of PDH activity. However, the total NADH content was measured in whole muscle tissue, and it is only the mitochondrial NADH that affects PDH activity. This, however, represents by far the biggest part of the total NADH content (Sahlin & Katz, 1986; Dash et al. 2008; Li et al. 2009; White & Schenk, 2012). The mechanism by which AMPK activation during exercise regulates PDK4 protein content in skeletal muscle could be in multiple steps from transcription to trans- lation in the synthesis process of new protein as wellas stability of the protein. In the present study, PDK4 mRNA was shown to increase (P = 0.05) after a single C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4776 A. M. Fritzen and others J Physiol 593.21 bout of exercise in both AMPKα2 KO and WT muscle. This is in line with previous findings after both a single AICAR injection and treadmill exercise in the same mouse model (Jørgensen et al. 2005). Together these findings clearly demonstrate that defective AMPKα2 does not robustly affect exercise-induced gene expression of PDK4. However, mRNA levels do not necessarily reflect trans- criptional activity. To further investigate exercise-induced PDK4 transcription, the activation of the two major regulators of transcription, SIRT1 and HDAC4, inducing PDK4 transcription (Fulco et al. 2003; Furuyama et al. 2003; Brunet et al. 2004; Gerhart-Hines et al. 2007; Cantó et al. 2009; Mihaylova et al. 2011), were studied. Exercise induced a similar increase in NAD+ content and a decrease in acetylation of p53, implying a similar activation of the NAD+ dependent deacetylase SIRT1 in both genotypes. Likewise, exercise decreased HDAC4 phosphorylation similarly in the two genotypes, which is expected to result in a similar exclusion of HDAC4 from the nucleus, thereby activating the FoxO1 transcription factor (Mihaylova et al. 2011) and accordingly inducing PDK4 transcription. Collectively, this supports the finding of a similar exercise-induced increase in PDK4 mRNA in the two genotypes. The lack of an effect of AMPKα2 depletion on exercise-induced SIRT1 activation is in contrast to studies in C2C12 myotubes transfected with a retrovirus expressing a dominant negative form of AMPK during glucose restriction (Fulco et al. 2008) and mouse muscle deficient in AMPKγ3 performing swimming exercise (Cantó et al. 2010) showing AMPK to be necessary for activation of SIRT1. These discrepancies are difficult to explain, but could be due to compensatory up-regulation of AMPKα1 protein expression in AMPKα2 KO muscle (Jørgensen et al. 2005, 2007) or more likely a difference in the response to different exercise regimes. The robust finding of an increased PDK4 protein expression in muscle of WT mice already after 2 h of exercise is striking. Previous studies have shown that 40–90 min of treadmill running in mice (Jørgensen et al. 2005; Cantó et al. 2009; Kiilerich et al. 2010) and 60–150 min of exercise in humans (Pilegaard et al. 2000, 2002, 2005) induced a 2- to 8-fold increase in PDK4 transcriptional activity and/or mRNA level in muscle immediately after or in the hours after exercise. It seems that the prolonged, exhaustive exercise bout with a depletion of energy stores and high substrate flux in mice has been the foundation for the increase in PDK4 protein within just 2 h of exercise. The exercise-induced increase in PDK4 protein expression observed only in WT mice, despite similar PDK4 mRNA levels between WT and AMPKα2 KO muscle, point towards a role of AMPK in post-transcriptional regulation of PDK4 protein. Recently, 4 A B C D E F P=0.05 3 2 1 0 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 2.0 1.5 1.0 0.5 0.0 80 60 40 20 0 p H D A C 4 S e r6 3 2 /H D A C 4 ( A U ) P D K 4 m R N A /s s D N A N A D + c o n te n t (n m o l/ m g d .w .) A c e ty la ti o n p 5 3 L y s 3 7 9 /p 5 3 p ro te in ( A U ) m iR -1 0 7 ( A U ) Rest Rest Exercise Rest Exercise Rest Exercise HDAC4 phosphorylation PDK4 mRNA NAD+ miR-107 p53 acetylation Rest Exercise Exercise WT AMPKα KO WT AMPKα KO WT AMPKα KO Re ReEx Ex 50 kDa 50 kDa 100 kDa 100 kDa AMPKα2KOWT p53 a-p53 pHDAC4 HDAC4 WT AMPKα KO WT AMPKα KO Figure 5. Similar exercise-induced increase in PDK4 mRNA levels, p53 acetylation and decreased HDAC4 phosphorylation in AMPKα2 KO and WT muscle PDK4 mRNA levels (A), NAD+ content (B), p53 Lys379 acetylation/p53 protein (C), HDAC4 Ser632 phosphorylation/HDAC4 protein (D), and miR-107 gene expression (E) in quadriceps muscle at rest and immediately after 2 h of treadmill exercise. F, representative immunoblots. Data are presented as means ± SEM. n = 7–10. #P < 0.05, ##P < 0.01, ###P < 0.001 main effect of exercise. AU, arbitrary units; Ex, exercise; d.w., dry weight; Re, rest. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4777 AMPK activation was shown to suppress endothelial cell expression of angiotensin converting enzyme post-translationally by phosphorylation of p53 and up-regulation of microRNA (miR) 143/145 (Kohlstedt et al. 2013) suggesting a role for AMPK in translational regulation through miR-mediated regulation. miR-107 was predicted to regulate PDK4 translation (Wilfred et al. 2007) and suggested to be important in the regulation of PDK4 protein content after exercise in mouse muscle (Safdar et al. 2009). However, the observation that miR-107 expression was independent of genotype and not affected by exercise suggests that AMPKα2 does not regulate the protein abundance of PDK4 via a miR-107-induced regulation. The observed genotypic difference in substrate selection during post-exercise recovery could not be explained by differences in circulating FA and TG concentrations or lipoprotein lipase activity in skeletal muscle. Furthermore, muscle malonyl-CoA levels, which have been associated with enhanced FA oxidation during post-exercise recovery in rat skeletal muscle (Rasmussen et al. 1998), cannot explain the difference in FA oxidation during recovery in the present study, as malonyl-CoA content was similar between WT and AMPKα2 KO muscle both immediately after exercise and 6 h post-exercise. The level of free carnitine and free CoA availability, which are both involved in the conversion of FAs into fatty acylcarnitines (van Loon et al. 2001; Roepstorff et al. 2005; Jeppesen et al. 2013), the form required for mitochondrial FA trans- membrane transport, did not differ between genotypes. Taken together this suggests that AMPK is critical for mitochondrial substrate selection towards FA oxidation in the post-exercise period through regulation of the PDH complex. Importantly, the high FA oxidation during AMPK γ NADH PDK4 pyruvate acetyl-CoA FA OXGLU OX PDH Thr172 AM P α2 β Figure 6. Scheme of proposed AMPK-mediated regulation of fuel selection during post-exercise recovery Exercise-induced increase in AMPKα2 activity in skeletal muscle increases pyruvate dehydrogenase 4 (PDK4) protein content, and AMPKα2 seems also to be crucial for NADH levels. Both inhibit pyruvate dehydrogenase (PDH) activity, whereby conversion of pyruvate to acetyl-CoA is inhibited and consequently glucose oxidation (GLU OX). This enables increased fatty acid oxidation (FA OX). recovery enables resynthesis of glucose towards muscle glycogen rather than oxidation as shown by calculated lower average muscle glycogen storage post-exercise in AMPKα2 KO mice. This is in line with earlier observations showing lower muscle glycogen levels during the post-exercise recovery period in muscle lacking functional AMPKα2 (Mu et al. 2003; Jørgensen et al. 2005) or AMPKγ3 (Barnes et al. 2004), although different recovery time periods have been examined. A potential limitation in the study could be that food intake during the post-exercise recovery period was not measured. However, it has previously been observed that food intake in AMPKα2 KO mice is similar to WT (Viollet et al. 2003). Moreover, in the present study, WT mice utilized a greater amount of energy and muscle glycogen during the exercise bout at the same relative intensity as AMPKα2 KO mice. If anything this would be expected to lead to a higher intake of carbohydrate-rich chow food, resulting in a higher RER in WT post-exercise. But the opposite was observed. Thus, taken together, it seems unlikely that potential differencesin food intake post-exercise can explain the observed findings in the pre- sent study. In conclusion, we here propose a mechanism responsible for the established observation of a higher FA oxidation during post-exercise recovery in favour of resynthesis of muscle glycogen stores (see Fig. 6). Thus, the present findings demonstrate that AMPKα2 plays an important, but indirect role, in increasing FA oxidation in muscle during post-exercise recovery. This seems to occur through an AMPKα2–PDK4-mediated inhibition of the mitochondrial PDH complex, and not through a reduction in muscle malonyl-CoA levels or changes in free carnitine or CoA availability. The inhibition of PDH activity decreases carbohydrate oxidation creating a demand for FA oxidation following exercise. Consequently, the glucose taken by muscle is directed primarily for glycogen synthesis rather than oxidation. References Barnes BR, Marklund S, Steiler TL, Walter M, Hjalm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR & Andersson L (2004). The 5’-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279, 38441–38447. Bielinski R, Schutz Y & Jequier E (1985). Energy metabolism during the postexercise recovery in man. Am J Clin Nutr 42, 69–82. Bowker-Kinley MM, Davis WI, Wu P, Harris RA & Popov KM (1998). Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329, 191–196. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4778 A. M. Fritzen and others J Physiol 593.21 Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW & Greenberg ME (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015. Calles-Escandon J, Goran MI, O’Connell M, Nair KS & Danforth E Jr (1996). Exercise increases fat oxidation at rest unrelated to changes in energy balance or lipolysis. Am J Physiol 270, E1009–E1014. Cantó C & Auwerx J (2011). Calorie restriction: is AMPK a key sensor and effector? Physiology (Bethesda) 26, 214–224. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P & Auwerx J (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056–1060. Cantó C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR & Auwerx J (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11, 213–219. Cederblad G, Carlin JI, Constantin-Teodosiu D, Harper P & Hultman E (1990). Radioisotopic assays of CoASH and carnitine and their acetylated forms in human skeletal muscle. Anal Biochem 185, 274–278. Chomczynski P & Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156–159. Cooper RH, Randle PJ & Denton RM (1975). Stimulation of phosphorylation and inactivation of pyruvate dehydrogenase by physiological inhibitors of the pyruvate dehydrogenase reaction. Nature 257, 808–809. Dash RK, Li Y, Kim J, Beard DA, Saidel GM & Cabrera ME (2008). Metabolic dynamics in skeletal muscle during acute reduction in blood flow and oxygen supply to mitochondria: in-silico studies using a multi-scale, top-down integrated model. PLoS One 3, e3168. Fentz J, Kjobsted R, Birk JB, Jordy AB, Jeppesen J, Thorsen K, Schjerling P, Kiens B, Jessen N, Viollet B & Wojtaszewski JF (2015). AMPKα is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice. FASEB J 29, 1725–1738. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA & Sartorelli V (2008). Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14, 661–673. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL & Sartorelli V (2003). Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12, 51–62. Furuyama T, Kitayama K, Yamashita H & Mori N (2003). Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 375, 365–371. Garland PB (1964). Some kinetic properties of pig-heart oxoglutarate dehydrogenase that provide a basis for metabolic control of the enzyme activity and also a stoichiometric assay for coenzyme A in tissue extracts. Biochem J 92, 10C–12C. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z & Puigserver P (2007). Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J 26, 1913–1923. Hardie DG (2008). Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett 582, 81–89. Herbst EA, Dunford EC, Harris RA, Vandenboom R, Leblanc PJ, Roy BD, Jeoung NH & Peters SJ (2012). Role of pyruvate dehydrogenase kinase 4 in regulating PDH activation during acute muscle contraction. Appl Physiol Nutr Metab 37, 48–52. Herbst EA, MacPherson RE, Leblanc PJ, Roy BD, Jeoung NH, Harris RA & Peters SJ (2014). Pyruvate dehydrogenase kinase-4 contributes to the recirculation of gluconeogenic precursors during postexercise glycogen recovery. Am J Physiol Regul Integr Comp Physiol 306, R102–R107. Horton TJ, Pagliassotti MJ, Hobbs K & Hill JO (1998). Fuel metabolism in men and women during and after long-duration exercise. J Appl Physiol (1985) 85, 1823–1832. Houten SM, Chegary M, Te BH, Wijnen WJ, Glatz JF, Luiken JJ, Wijburg FA & Wanders RJ (2009). Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids. Cell Mol Life Sci 66, 1283–1294. Jeppesen J, Maarbjerg SJ, Jordy AB, Fritzen AM, Pehmoller C, Sylow L, Serup AK, Jessen N, Thorsen K, Prats C, Qvortrup K, Dyck JR, Hunter RW, Sakamoto K, Thomson DM, Schjerling P, Wojtaszewski JF, Richter EA & Kiens B (2013). LKB1 regulates lipid oxidation during exercise independently of AMPK. Diabetes 62, 1490–1499. Jeppesen J, Mogensen M, Prats C, Sahlin K, Madsen K & Kiens B (2010). FAT/CD36 is localized in sarcolemma and in vesicle-like structures in subsarcolemma regions but not in mitochondria. J Lipid Res 51, 1504–1512. Jørgensen SB, Treebak JT, Viollet B, Schjerling P, Vaulont S, Wojtaszewski JF & Richter EA (2007). Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab 292, E331–E339. Jørgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA & Wojtaszewski JF (2004). Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279, 1070–1079. Jørgensen SB, Wojtaszewski JF, Viollet B, Andreelli F, Birk JB, Hellsten Y, Schjerling P, Vaulont S, Neufer PD, Richter EA & Pilegaard H (2005). Effects of α-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J 19, 1146–1148. Kiens B, Lithell H, Mikines KJ & Richter EA (1989). Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action. J Clin Invest 84, 1124–1129. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society J Physiol 593.21 AMPK controls substrate metabolism during post-exercise recovery 4779 Kiens B & Richter EA (1998). Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans. Am J Physiol 275, E332–E337. Kiilerich K, Adser H, Jakobsen AH, Pedersen PA, Hardie DG, Wojtaszewski JF & Pilegaard H (2010). PGC-1α increases PDH contentbut does not change acute PDH regulation in mouse skeletal muscle. Am J Physiol Regul Integr Comp Physiol 299, R1350–R1359. Kimber NE, Heigenhauser GJ, Spriet LL & Dyck DJ (2003). Skeletal muscle fat and carbohydrate metabolism during recovery from glycogen-depleting exercise in humans. J Physiol 548, 919–927. Klein DK, Pilegaard H, Treebak JT, Jensen TE, Viollet B, Schjerling P & Wojtaszewski JF (2007). Lack of AMPKα2 enhances pyruvate dehydrogenase activity during exercise. Am J Physiol Endocrinol Metab 293, E1242–E1249. Kohlstedt K, Trouvain C, Boettger T, Shi L, Fisslthaler B & Fleming I (2013). AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res 112, 1150–1158. Krzentowski G, Pirnay F, Luyckx AS, Pallikarakis N, Lacroix M, Mosora F & Lefebvre PJ (1982). Metabolic adaptations in post-exercise recovery. Clin Physiol 2, 277–288. Li Y, Dash RK, Kim J, Saidel GM & Cabrera ME (2009). Role of NADH/NAD+ transport activity and glycogen store on skeletal muscle energy metabolism during exercise: in silico studies. Am J Physiol Cell Physiol 296, C25–C46. Linn TC, Pettit FH & Reed LJ (1969). α-Keto acid dehydrogenase complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc Natl Acad Sci USA 62, 234–241. Lithell H & Boberg J (1978). Determination of lipoprotein-lipase activity in human skeletal muscle tissue. Biochim Biophys Acta 528, 58–68. Lowry OH & Passonneau JV (1972). A Flexible System of Enzymatic Analysis. Academic Press, Inc., NY, USA. Lundby C, Gassmann M & Pilegaard H (2006). Regular endurance training reduces the exercise induced HIF-1α and HIF-2α mRNA expression in human skeletal muscle in normoxic conditions. Eur J Appl Physiol 96, 363–369. Maarbjerg SJ, Jørgensen SB, Rose AJ, Jeppesen J, Jensen TE, Treebak JT, Birk JB, Schjerling P, Wojtaszewski JF & Richter EA (2009). Genetic impairment of AMPKα2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice. Am J Physiol Endocrinol Metab 297, E924–E934. McGee SL, Fairlie E, Garnham AP & Hargreaves M (2009). Exercise-induced histone modifications in human skeletal muscle. J Physiol 587, 5951–5958. Maehlum S, Grandmontagne M, Newsholme EA & Sejersted OM (1986). Magnitude and duration of excess postexercise oxygen consumption in healthy young subjects. Metabolism 35, 425–429. Melby C, Scholl C, Edwards G & Bullough R (1993). Effect of acute resistance exercise on postexercise energy expenditure and resting metabolic rate. J Appl Physiol (1985) 75, 1847–1853. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, Downes M, Evans RM, Montminy M & Shaw RJ (2011). Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607–621. Mu J, Barton ER & Birnbaum MJ (2003). Selective suppression of AMP-activated protein kinase in skeletal muscle: update on ‘lazy mice’. Biochem Soc Trans 31, 236–241. O’Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jorgensen SB, Schertzer JD, Shyroka O, Kiens B, van Denderen BJ, Tarnopolsky MA, Kemp BE, Richter EA & Steinberg GR (2011). AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci USA 108, 16092–16097. Passonneau JV, Gatfield PD, Schulz DW & Lowry OH (1967). An enzymic method for measurement of glycogen. Anal Biochem 19, 315–326. Pilegaard H, Birk JB, Sacchetti M, Mourtzakis M, Hardie DG, Stewart G, Neufer PD, Saltin B, van Hall G & Wojtaszewski JF (2006). PDH-E1α dephosphorylation and activation in human skeletal muscle during exercise: effect of intralipid infusion. Diabetes 55, 3020–3027. Pilegaard H, Keller C, Steensberg A, Helge JW, Pedersen BK, Saltin B & Neufer PD (2002). Influence of pre-exercise muscle glycogen content on exercise-induced transcriptional regulation of metabolic genes. J Physiol 541, 261–271. Pilegaard H, Ordway GA, Saltin B & Neufer PD (2000). Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279, E806–E814. Pilegaard H, Osada T, Andersen LT, Helge JW, Saltin B & Neufer PD (2005). Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. Metabolism 54, 1048–1055. Rasmussen BB, Hancock CR & Winder WW (1998). Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. J Appl Physiol (1985) 85, 1629–1634. Ravindran S, Radke GA, Guest JR & Roche TE (1996). Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity. J Biol Chem 271, 653–662. Richter EA & Ruderman NB (2009). AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J 418, 261–275. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA & Kiens B (2005). Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 288, E133–E142. Rowles J, Scherer SW, Xi T, Majer M, Nickle DC, Rommens JM, Popov KM, Harris RA, Riebow NL, Xia J, Tsui LC, Bogardus C & Prochazka M (1996). Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem 271, 22376–22382. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society 4780 A. M. Fritzen and others J Physiol 593.21 Safdar A, Abadi A, Akhtar M, Hettinga BP & Tarnopolsky MA (2009). miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLoS One 4, e5610. Sahlin K & Katz A (1986). The content of NADH in rat skeletal muscle at rest and after cyanide poisoning. Biochem J 239, 245–248. Stanley WC, Hernandez LA, Spires D, Bringas J, Wallace S & McCormack JG (1996). Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. J Mol Cell Cardiol 28, 905–914. Sugden MC, Grimshaw RM & Holness MJ (1993). The regulation of hepatic carbon flux by pyruvate dehydrogenase and pyruvate dehydrogenase kinase during long-term food restriction. Biochem J 296, 217–223. Thomson DM, Brown JD, Fillmore N, Condon BM, Kim HJ, Barrow JR & Winder WW (2007). LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle. Am J Physiol Endocrinol Metab 293, E1572–E1579. Treuth MS, Hunter GR & Williams M (1996). Effects of exercise intensity on 24-h energy expenditure and substrate oxidation. Med Sci Sports Exerc 28, 1138–1143. van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH & Wagenmakers AJ (2001). The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536, 295–304. Viollet B, Andreelli F, Jørgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R & Vaulont S (2003). The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111, 91–98. Weststrate JA, Weys P, Poortvliet E, Deurenberg P & Hautvast JG (1990). Lack of a systematic sustained effect of prolonged exercise bouts on resting metabolic rate in fasting subjects. Eur J Clin Nutr 44, 91–97. White AT & Schenk S (2012). NAD+/NADH and skeletal muscle mitochondrial adaptations to exercise. Am J Physiol Endocrinol Metab 303, E308–E321. Wilfred BR, Wang WX & Nelson PT (2007). Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 91,209–217. Wolfe RR, Klein S, Carraro F & Weber JM (1990). Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 258, E382–E389. Additional information Competing interests The authors declare there are no conflicts of interest. Author contributions A.M.F., J.J., M.L.B.C. and B.K. designed and conceived the study. A.M.F., J.J., M.L.B.C., A.-M.L., R.B. and H.P. collected and analysed data. The experiments were carried out at the University of Copenhagen, Denmark, in the Molecular Physiology Group, Department of Nutrition, Exercise and Sports. A.M.F. and B.K. wrote the manuscript with all co-authors revising it critically for important intellectual content. All authors have approved the final version of the manuscript and agree to be accountable for all aspects of the work. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed. Funding The study was supported by funding from the Novo Nordisk Foundation (R168-A14319 to B.K.), the Lundbeck Foundation (R17-A1760 to B.K.) and The Danish Council for Independent Research – Natural Sciences (1323-00317A to H.P.). The PhD Scholarship of Anne-Marie Lundsgaard was funded by The Danish Diabetes Academy which is supported by the Novo Nordisk Foundation. Acknowledgements The authors are grateful for the skilled technical assistance of I.B. Nielsen, Molecular Physiology Group, Department of Exercise and Sport Sciences, University of Copenhagen. The authors thank Professor B. Viollet (Department of End- ocrinology, Metabolism and Cancer, Institut Cochin, Université Paris Decartes, Paris, France) for providing the AMPKα1 and AMPKα2 KO founder mice. We also thank D. Grahame Hardie (Dundee University, UK) for the kind donation of the anti-AMPKα1, anti-AMPKα2, anti-PDH-1Eα, anti-pPDH-1Eα Ser293, anti-pPDH-1Eα Ser300 and anti-PDK4 antibodies for this study. C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
Compartilhar